Researchers are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans
Penn study suggests that targeting amyloid fibrils could prevent sexual transmission
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.